US Executive Officer Management Changes SEC — July 10, 2026

10-07-2026

ZyVersa Therapeutics disclosed that independent director Min Chul Park, Ph.D. resigned effective July 8, 2026, for personal reasons and not due to any disagreement with the company. The company is exploring cost-cutting measures including voluntary pay reductions by CEO Stephen Glover and CFO Peter Wolfe, possible divestiture of product candidates VAR 200 or IC 100, employee headcount reductions, and considering going dark by suspending SEC filing obligations. While management is taking steps to preserve cash, the measures signal significant financial distress, with no new financing secured yet.

• · CEO Stephen Glover and CFO Peter Wolfe each voluntarily agreed to accept reduced compensation to support the company during a period of limited cash resources.
• · The company is considering divesting or selling its VAR 200 or IC 100 product candidates.
• · Employee headcount reduction is being considered to focus on core services and support.
• · The company may 'go dark' by suspending its obligations to file periodic reports under the Securities Exchange Act of 1934.
• · Other alternatives such as sale of the company or its assets, restructuring, or reorganization are also being considered.
• · The company expects any savings from cost-reduction activities along with any capital raise may enable continued operations, but no new financing has been secured yet.

10-07-2026

Alpha and Omega Semiconductor Limited (AOSL) appointed Joshua Chien as an independent director on July 8, 2026, effective immediately. Mr. Chien brings extensive experience in business development, supply chain strategy, and operational leadership from roles at Sonatus, SMTC Corporation, and Sanmina Corporation. The appointment is part of the company's efforts to strengthen its board and execute strategic priorities.

• · Joshua Chien served as Chief Commercial Officer of SMTC Corporation from 2021 to April 2026, achieving more than fourfold revenue growth.
• · He currently serves as Executive Vice President, Product & Strategy Officer at Sonatus, Inc., an AI-enabling mobility software company.
• · Mr. Chien holds a Bachelor of Arts in Economics from UC Berkeley and completed the Finance for Executives program at Harvard Business School.

10-07-2026

Cadrenal Therapeutics, Inc. (CVKD) announced the resignation of Chief Medical Officer Dr. James J. Ferguson III, effective July 31, 2026. The company has initiated a search for a replacement and is negotiating a separation agreement. The departure of a key officer introduces leadership uncertainty during a critical period for the company's clinical development.

• · Dr. Ferguson's resignation was announced on July 7, 2026, with an effective date of July 31, 2026.
• · The separation agreement and release are still being negotiated and have not yet been finalized.
• · The company is actively searching for a replacement Chief Medical Officer.

10-07-2026

Veritone, Inc. filed a Certificate of Amendment to its Fourth Amended and Restated Certificate of Incorporation on July 10, 2026, increasing the authorized common stock from 200,000,000 shares to 225,000,000 shares and reducing the authorized preferred stock from 10,000,000 shares to 1,000,000 shares. The amendment was approved by the board of directors and stockholders and takes effect upon filing. The filing also covers director/officer departure/election matters under Items 5.02, 5.03, 5.07, and 9.01.

• · The amendment was effective upon filing on July 10, 2026.
• · The filing also reports on Items 5.02, 5.03, 5.07, and 9.01, which typically cover director/officer changes, amendment to articles of incorporation, submission of matters to a vote of security holders, and financial statements/exhibits, respectively.
• · No financial results or specific director/officer departure/election details were provided in the accessible content; only the charter amendment exhibit was included.

10-07-2026

On July 6, 2026, George Holding resigned from the Board of Directors of Trump Media & Technology Group Corp., effective immediately. His resignation did not arise from any dispute with management or the Board. The company expressed gratitude for his service.

• · Resignation was effective immediately on July 6, 2026.
• · Mr. Holding also resigned from all committees on which he served.
• · The resignation was not related to any dispute with management or the Board.

10-07-2026

Sterling Infrastructure, Inc. announced that Mark D. Wolf, its General Counsel, Chief Compliance Officer and Corporate Secretary, notified the company of his intention to retire later this year. Mr. Wolf is expected to continue in his current role and assist in the transition.

• · The retirement notification was made on July 6, 2026.
• · Mr. Wolf will continue in his current role and assist in the transition.

10-07-2026

Mary Junck informed the Board of Lee Enterprises that she is retiring from the Board effective July 31, 2026. The departure is not due to any disagreements with the company. No financial impact or other material changes were disclosed.

• · Mary Junck's retirement is effective July 31, 2026.
• · No disagreements exist between Junck and the company regarding operations, policies, or practices.

10-07-2026

MDWerks, Inc. (OTCQB: MDWK) announced the appointment of Jeff Hopmayer to its Board of Directors as the company transitions from technology development to commercial execution. The company reports an independently appraised IP portfolio valued at approximately $400 million, signed commercial contracts, and initial customer deployments beginning in Q2 2026, with estimated addressable markets exceeding $1.8 trillion globally. However, the filing contains no current revenue or profit figures, and the company remains in an early commercial stage with no disclosed financial performance metrics.

• · First commercial deployment of the Molecular Sawdust Drying System (MSDS) has recently begun.
• · Customer deployments began in Q2 2026.
• · The company's patent estate includes issued and pending patents worldwide.
• · MDWerks initially commercialized its platform in the beverage alcohol industry for flavor enhancement and extraction.
• · Potential applications include desalination, water purification, wastewater treatment, chemical extraction, food production, pharmaceuticals, agriculture, engineered materials, and advanced manufacturing.

10-07-2026

On July 8, 2026, Dr. Kairat Kelimbetov resigned from the Board of Directors of Freedom Holding Corp., effective immediately, reducing board size from seven to six directors. The resignation was not due to any disagreement with the company's operations, policies, or practices. No financial impact or other material changes were disclosed.

• · Resignation effective immediately on July 8, 2026.
• · Board size decreased from 7 to 6 directors.
• · No disagreement cited as reason for resignation.

10-07-2026

Enova International announced the appointment of Maria Veltre to its Board of Directors, effective immediately, while William M. Goodyear and Mark McGowan retired as part of a planned board transition. The changes are not related to any disagreement with the company. The announcement also references the company's pending acquisition of Grasshopper Bank.

• · Maria Veltre is an Operating Partner at Lightyear Capital and previously served as US Head of Digital and Innovation at Santander US, CMO for Fifth Third Bank and Citi's Small Business unit.
• · William M. Goodyear and Mark McGowan resigned as part of a planned board transition, with no disagreement with the company.
• · Enova has provided approximately $70 billion in loans and financing to nearly 15 million customers over 20+ years.

10-07-2026

On July 7, 2026, the Board of Directors of Team, Inc. approved an amendment to its Corporate Executive Officer Compensation and Benefits Continuation Policy, reducing change-in-control severance benefits. The amendment caps supplemental salary payments at 24 months (down from longer periods) and modifies the calculation of supplemental compensation for forgone bonuses to use the higher of the most recent year's actual bonus or the two-year average, or target bonus if none paid. This change reduces potential executive payout obligations but does not involve any director or officer departure or election.

• · The amendment applies only to Section III of the Policy (Severance Benefits for Involuntary Separation from Service Without Cause or Voluntary Separation from Service for Good Reason Related to Change in Control).
• · Supplemental compensation for forgone annual incentive/bonus is now calculated using the higher of the most recent year's actual bonus or the two-year average; if no bonus has been received, target bonus is used.
• · The supplemental compensation payment is made as a single lump sum on the same date as the supplemental salary payment.
• · The amendment does not affect other sections of the Policy or other compensatory arrangements.

10-07-2026

Adient plc announced on July 6, 2026, that EVP and CFO Mark Oswald intends to leave the company by December 31, 2026, with no disagreement over operations, policies, or practices. The company has initiated an external search for a new CFO. No financial figures or performance metrics are provided in this filing.

• · Departure is not due to any disagreement with the company regarding operations, policies, or practices.
• · External search for next CFO has been initiated.
• · Mr. Oswald's last day is no later than December 31, 2026.

10-07-2026

On July 8, 2026, Axon Enterprise appointed Vivek Mohindra and Eiso Kant to its Board of Directors, effective immediately, to fill existing vacancies. Both are independent directors with terms expiring at the 2027 annual meeting. The appointments bring senior leadership experience from Dell Technologies and AI-focused startups, respectively, but no financial performance data is included in this filing.

• · Mr. Mohindra, 57, served at Dell Technologies from May 2020 to April 2026, most recently as Special Advisor to the Vice Chair and COO.
• · Mr. Kant, 35, is co-founder and CTO of poolside, and since July 2025 also co-CEO; he also co-founded and leads Poolside Infrastructure Company.
• · Mr. Mohindra holds a Ph.D. and M.S. in Chemical Engineering and an M.B.A. from MIT, and a B.E. from IIT Roorkee.
• · Mr. Kant studied business administration at IE University in Madrid, Spain.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K were identified for either director.

10-07-2026

Cerus Corporation filed an 8-K disclosing that William 'Obi' Greenman, former President and CEO, transitioned to Executive Chairman effective July 1, 2026, and entered into an amendment to his existing employment letter agreement on July 6, 2026. Under the amendment, he will receive an annual base salary of $500,000 and a 2026 target cash bonus of 80% of his 2026 base salary, but will not be eligible for a 2027 cash bonus. His anticipated time commitment is about 60% of full-time, and the role ends on May 31, 2027, unless extended.

• · The Executive Chairman role is anticipated to require a time commitment averaging about 60% of a full-time schedule.
• · Mr. Greenman's service as Executive Chairman ends on May 31, 2027, unless earlier terminated or extended by written agreement.
• · The amendment specifies that Mr. Greenman will not be entitled to an annual cash bonus for any portion of 2027.
• · The company will pay or reimburse COBRA premiums if Mr. Greenman's Executive Chairman service constitutes a qualifying event under COBRA and he remains compliant with the agreement.

10-07-2026

iQSTEL Inc. amended the employment agreements of its CEO and CFO on July 7, 2026, increasing CEO monthly base salary from $31,000 to $37,800 (including a relocation allowance) and granting a two-month cash performance bonus for relocation expenses. The board also approved equity compensation changes—replacing annual common stock grants with up to 50,000 Series B Preferred Shares per executive per year and granting 20,000 Series B Preferred Shares to the CEO and 14,000 to the CFO for FY-2025—but these equity changes are subject to shareholder approval under Nasdaq rules and will not take effect until approved. No financial results or period-over-period comparisons are provided in this filing.

• · The equity compensation changes are subject to shareholder approval under Nasdaq Listing Rule 5635(c) and will not become effective until approved.
• · The annual bonus payment timing was amended to allow payment 15 days after filing the 10-K.
• · The previous annual equity incentive allowed up to 1,000,000 common shares for the CEO and 800,000 common shares for the CFO; these were replaced with Series B Preferred Shares.

10-07-2026

On July 6, 2026, The Children's Place, Inc. announced that Kim Roy stepped down as Executive Director and employee, effective immediately, but will remain on the board. Her departure was not due to any disagreement with the company. A separation agreement is still being negotiated and will be disclosed in a future amendment.

• · The separation agreement has not yet been finalized; terms will be disclosed in an amendment to this 8-K.
• · Ms. Roy's departure was not the result of any disagreement with the company regarding operations, policies, or practices.

10-07-2026

O'Reilly Automotive appointed Colin Yankee as Executive Vice President and Chief Supply Chain Officer, effective July 13, 2026. Mr. Yankee brings over 20 years of retail supply chain experience from Tractor Supply Company, Neiman Marcus, and Target. His compensation includes a $700,000 base salary, an 85% annual incentive target, and a $500,000 hiring stock option award.

• · Mr. Yankee will be responsible for merchandise, inventory management, distribution operations, and transportation.
• · He will receive a stock option award with estimated future fair value of 100% of his annual base salary, granted at the same time as other executive officers.
• · He is eligible for other benefits and perquisites substantially similar to other executive officers.
• · The company entered into a change in control severance agreement with Mr. Yankee on same terms as other executive officers.
• · No family relationships or material transactions with the company were disclosed.

10-07-2026

O-I Glass, Inc. announced an organizational change on July 8, 2026, under which Emmanuelle Guérin will step down as Senior Vice President, Business Operations Europe, effective immediately. She will remain a non-executive employee on garden leave through September 30, 2026, receiving continued salary and benefits, and will be eligible for severance under the company's Executive Severance Policy. The filing does not disclose any financial impact or replacement, and no period-over-period comparisons are provided.

• · Emmanuelle Guérin's employment will terminate on September 30, 2026.
• · She is entitled to continuation of current salary and benefits through September 30, 2026.
• · Severance eligibility is under O-I Glass, Inc.'s Amended and Restated Executive Severance Policy.
• · No successor or interim replacement for the role has been announced.

10-07-2026

KBR, Inc. entered into amended and restated severance and change in control agreements with its executive officers, including the CEO and CFO, effective July 10, 2026. The amendments enhance severance multiples for non-CEO executives from 1.0x to 1.5x (base salary + target bonus), broaden the definition of 'Good Reason,' and clarify 'Cause' definitions, while also adding retirement eligibility criteria and pro-rata RSU vesting. The changes aim to provide fair and competitive treatment but do not materially modify change-in-control benefits.

• · The Galindo Agreement includes additional non-change-in-control severance enhancements: pro-rata annual bonus, pro-rata vesting of non-performance equity awards, and pro-rata vesting of performance-based awards.
• · The Galindo Agreement's non-compete clause includes an exception for the right to practice law.
• · Retirement eligibility requires sum of age and years of service ≥ 70, with minimum age 55 and at least 5 years of service, plus 6 months' prior written notice.
• · The agreements do not materially modify change-in-control severance payments and benefits.

10-07-2026

American Battery Technology Company (ABAT) entered into new two-year employment agreements with its CEO/CTO Ryan Melsert, CFO Alejandro Flores Arteaga, and COO Steven Wu, effective July 1, 2026. The agreements include annual salaries of $475,000 (CEO), $280,000 (CFO), and $350,000 (COO), plus performance-based cash bonuses (75% of salary target), RSUs ($1M CEO, $500K CFO, $750K COO), and stock options (3M, 1M, and 1.5M shares respectively at $2.76 per share). The compensation packages are designed to retain key executives and align incentives with strategic milestones, though no prior-period comparisons are available to assess changes.

• · Stock option exercise price is $2.76 per share, based on closing price on July 1, 2026.
• · RSUs and options vest 1/16th quarterly; FY2027 grants vest from July 1, 2026, FY2028 grants from July 1, 2027.
• · CEO options expire July 1, 2036 (FY2027) and July 1, 2037 (FY2028); CFO and COO options have same expiry dates.
• · Compensation Committee engaged an independent consultant and performed a market assessment before approving agreements.
• · No prior employment agreements or compensation data provided for period-over-period comparison.

10-07-2026

Forward Air Corp announced that Jerome Lorrain resigned as Executive Chairman effective July 10, 2026, but will remain on the Board as a non-employee director. His outstanding restricted stock awards will continue to vest while he serves on the Board, but his performance-based and special one-time equity awards tied to the strategic review were forfeited. The Board appointed independent director Christine M. Gorjanc as the new Chair.

• · Mr. Lorrain did not receive an annual equity award for 2026 under the non-employee director compensation program.
• · No compensatory arrangement was entered into other than the amendments to restricted stock award agreements.
• · Ms. Gorjanc's appointment was not made pursuant to any arrangement with any other person and no transactions require disclosure under Item 404(a).

10-07-2026

Via Transportation, Inc. announced the appointment of Matt Levine as Chief Legal Officer, effective July 27, 2026, succeeding Erin Abrams who will step down and transition to a senior advisory role until January 1, 2027. Matt Levine brings extensive legal and privacy experience from his prior roles at Clear Secure, Inc. and Success Academy Charter Schools. Erin Abrams, who has served Via since 2014, will ensure continuity during the transition.

• · Matt Levine previously served as General Counsel and Chief Privacy Officer at Clear Secure, Inc. from 2012 to 2024.
• · Erin Abrams will serve in a senior advisory role until January 1, 2027.
• · Erin Abrams joined Via in 2014, providing twelve years of service.

10-07-2026

Concentra Group Holdings Parent, Inc. disclosed a consulting agreement with retiring EVP and Chief Medical Officer Dr. John R. Anderson, effective January 1, 2027 through December 31, 2027. Dr. Anderson will provide up to 10 hours per week at $216 per hour, and his unvested restricted stock awards will continue to vest during the term, with an additional 25% automatic vesting upon completion of the full term. The agreement includes termination provisions and forfeiture of unvested equity if terminated for cause or if Dr. Anderson resigns early.

• · Dr. Anderson's retirement was previously announced on April 10, 2026, effective December 31, 2026.
• · The consulting agreement is with subsidiary Concentra Health Services, Inc.
• · Either party may terminate the agreement upon 30 days' written notice; Concentra may terminate immediately for cause.
• · Equity benefits require execution of a general release of claims at commencement and a final release upon termination.
• · The agreement is filed as Exhibit 10.1 to the 8-K.

10-07-2026

Kinetic Seas Inc. (KSEZ) announced the resignation of Director Robert Jackson, effective July 8, 2026, citing pursuit of other business ventures and a desire to avoid potential conflicts of interest. The departure is amicable, with Jackson expressing support for the company's mission and leadership. No financial figures or period-over-period comparisons are included in this filing.

• · Robert Jackson's resignation was effective immediately on July 8, 2026.
• · Jackson stated he is pursuing other business ventures and wants to avoid potential conflicts of interest.
• · The resignation letter was attached as Exhibit 17.1 and incorporated by reference.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

10-07-2026

HeartSciences Inc. entered into a Merger Agreement on June 23, 2026, under which its subsidiary Cordis Acquisition, LLC will merge with Fortitude Mining HoldCo, LLC, making HeartSciences the sole managing member of the surviving entity. In connection with the transaction, the company amended CFO Danielle Watson's employment agreement to provide enhanced severance benefits and granted her 25,000 restricted stock units that vest over one year post-closing. The filing does not disclose financial terms of the merger or any period-over-period performance data.

• · The RSUs vest in four equal quarterly installments beginning three months after closing, with full vesting on the one-year anniversary of closing.
• · If Ms. Watson is terminated without cause or resigns for good reason, all unvested RSUs accelerate immediately; if terminated for cause, unvested RSUs are forfeited.
• · The severance package includes six months of base salary in a lump sum, COBRA premium reimbursement for up to six months, and 100% acceleration of unvested equity awards granted pre-closing.
• · The merger requires stockholder approval; a proxy statement will be filed with the SEC.
• · The offering of the Equity Award is claimed to be exempt from registration under Section 4(a)(2) and/or Rule 506(b) of Regulation D.

10-07-2026

On July 9, 2026, Peter L. Gray resigned immediately as President of Lands' End Licensing, Chief Administrative Officer, and General Counsel of Lands' End, Inc. and all subsidiary positions. The filing does not disclose a successor or any financial impact, but the sudden departure of a top executive may signal organizational changes.

• · Resignation effective immediately on July 9, 2026.
• · Gray held three key roles: President of Lands' End Licensing, Chief Administrative Officer, and General Counsel.
• · No successor or interim replacement has been announced.
• · The filing does not provide a reason for the resignation.

10-07-2026

National Healthcare Properties, Inc. extended the employment agreement of CEO and President Michael Anderson from September 27, 2027 to September 27, 2030, with automatic one-year renewals thereafter unless either party gives 90 days' notice. The amendment did not change any other terms of the agreement, including compensation. No financial figures or performance metrics were disclosed in this filing.

• · The amendment was entered into on July 7, 2026, and filed on July 10, 2026.
• · The original employment agreement term was set to expire on September 27, 2027.
• · The new term extends to September 27, 2030, with automatic one-year renewals.
• · No changes were made to the compensatory terms of the agreement.

10-07-2026

DarioHealth Corp. disclosed on July 10, 2026, that the temporary medical leave of absence of Steven Nelson, President and Chief Commercial Officer, has been extended for an indefinite period. During his absence, his responsibilities are being assumed by members of the company's senior management team. No financial impact or performance metrics were provided in this filing.

• · The leave extension is for an indefinite period.
• · No replacement or interim appointment has been announced; responsibilities are being covered by existing senior management.

10-07-2026

Cellectar Biosciences held its 2026 Annual Meeting on July 7, 2026, where stockholders approved all proposals, including the election of Class III directors Andrew Gu and Douglas J. Swirsky, an increase in shares reserved under the 2021 Stock Incentive Plan by 2,000,000 shares, ratification of Deloitte & Touche LLP as auditor for fiscal year 2026, advisory approval of executive compensation, and the exercise of warrants for up to 39,618,078 shares of common stock. The adjournment proposal was mooted after the warrant exercise proposal passed. All votes passed with majority support, though the executive compensation proposal saw notable opposition with 712,362 votes against (33.1% of votes cast excluding broker non-votes).

• · The warrant exercise proposal allows the company to issue up to 39,618,078 shares of common stock upon exercise of outstanding warrants.
• · The adjournment proposal was not presented because the warrant exercise proposal passed.
• · The executive compensation proposal received 712,362 votes against, representing about 33.1% of votes cast (excluding broker non-votes), indicating significant shareholder dissent.
• · The increase in shares under the Plan passed with 1,706,640 for and 439,422 against (20.5% against of votes cast excluding broker non-votes).

10-07-2026

Ategrity Specialty Insurance Co Holdings pre-announced record preliminary Q2 2026 results, with gross written premiums exceeding $205 million (up >22% YoY), a combined ratio below 87%, and diluted EPS above $0.60 (vs. consensus of $0.47). Net income attributable to stockholders grew more than 75% YoY. Separately, the company appointed Neil Adler as CFO, effective July 9, 2026, succeeding Neelam Patel whose employment agreement was not renewed. While the financial metrics show strong growth and profitability, the CFO transition introduces a leadership change that may warrant monitoring.

• · Growth was broad-based with >20% in both property and casualty lines.
• · Newer initiatives including New England strategy and recently launched products began contributing meaningfully.
• · The company benefited from an intensified market focus on terms and conditions, particularly in the middle-market segment.
• · Neil Adler previously served as CFO of Zimmer Financial Services Group since January 2026 and CFO of Zimmer Partners since August 2025.
• · Neelam Patel's employment agreement was not renewed upon its scheduled expiration.

10-07-2026

CNB Financial Corporation announced the resignation of board member Gary Olson for personal reasons, effective July 31, 2026. Mr. Olson also resigned from the board of the company's subsidiary bank, CNB Bank. The resignation was not due to any disagreement with the company regarding operations, policies, or practices.

• · Resignation effective July 31, 2026
• · Resignation also from CNB Bank board
• · No disagreement cited as reason for departure

10-07-2026

AppTech Payments Corp. announced the immediate removal of Thomas J. DeRosa as President and CEO effective July 1, 2026, though he remains on the Board. Felipe A. Corrado IV, the current CFO and Treasurer, was appointed Interim CEO with a compensation increase to $300,000. The filing does not disclose any financial metrics or performance data, so no period-over-period comparisons are available.

• · Thomas J. DeRosa was released from his roles as President and CEO effective July 1, 2026, but continues as a Board member.
• · Felipe A. Corrado IV, age 47, was appointed Interim CEO on July 1, 2026, while retaining his CFO and Treasurer roles.
• · Corrado has served as CFO and Treasurer since December 2024 and was a Management Consultant at the Company since 2021.
• · Corrado has over two decades of experience including roles at Walt Disney Records, PricewaterhouseCoopers, and BDO, LLP.
• · Corrado's compensation was changed to $300,000 in connection with the appointment.
• · No arrangements or understandings exist between Corrado and any other person regarding his appointment, and no family relationships with other directors or officers.